Skip to content
Search

Latest Stories

‘Duty of Candour is not an add-on, it’s a fundamental part of pharmacy profession’

The General Pharmaceutical Council (GPhC) has developed two new resources- Keeping patients safe being open and honest and Pharmacy team toolkit – learning from incidents, to help pharmacists and pharmacy technicians fulfil the duty of candour – the professional responsibility to be open and honest with patients if/when something goes wrong.

The new resources bring together relevant existing policy, standards, and previous statements on the professional obligations of pharmacists and pharmacy technicians, with respect to candour.


It also emphasises that the duty of candour is not an add on – it’s a fundamental part of pharmacy professional practice.

The responsibility to be open and honest applies even in difficult or challenging times and it’s essential that professionals do the right thing for patients, their families and carers. Saying sorry meaningfully when things go wrong is vital for everyone involved.

Given the link with issues around liability and indemnity, the National Pharmacy Association and the Pharmacists’ Defence Association – as leading providers of professional indemnity - have also contributed to the new resources and highlighted the importance of openness and transparency in this context.

The additional toolkit for pharmacy teams includes real case studies and examples of notable practice about how pharmacy teams have learned from incidents, to improve patient safety outcomes and minimise the risk of these happening again.

All pharmacy teams are urged to use the new toolkit to prompt learning and reflection during pharmacy team meetings or other discussions. Whilst the toolkit examples are drawn from the GPhC’s inspections of community pharmacies, the professional duty to be candid applies in all sectors of pharmacy practice.

Roundtable on Duty of Candour

Chair of the GPhC, Gisela Abbam, hosted a roundtable meeting on the duty of candour on Monday (June 13), attended by the Chief Pharmaceutical Officers and organisations representing pharmacy professionals, employers and students, patients and the public and other regulators.

Gisela Abbam said: “All healthcare professionals have a duty of candour – this is a professional responsibility to be open and honest with patients when something goes wrong with their treatment or care which causes, or has the potential to cause, harm or distress.

“We know that pharmacy professionals are working in multi-disciplinary teams and taking on new clinical roles, and it’s important that they demonstrate the duty of candour in an increasing variety of complex situations.

“At our roundtable, we sought feedback on the new resources. We also discussed further actions that we can all take to make sure everyone working in pharmacy understands their responsibilities to be open and honest when things go wrong, and to improve patient safety.”

Chief executive of the GPhC, Duncan Rudkin, said: “Pharmacists and pharmacy technicians, across different settings, work hard to provide person-centred, safe and effective care to patients. But sometimes things go wrong. The way that professionals respond to these situations is key to supporting the people affected and improving patient safety for the future.

“Our new resources highlight the importance of saying sorry. Apologising to a patient does not mean that a professional is admitting legal liability for what has happened. It’s an acknowledgement that something could have gone better, and gives an opportunity for learning to improve patient safety outcomes and minimise the risk of the same thing happening again.”

Chief pharmaceutical officer for England, David Webb, said: “The duty of candour is an essential part of being a pharmacy professional in the NHS because it is fundamentally important to patients, families, carers and everyone who is involved.

“My experience is that when we take this approach, it is welcomed and engenders further trust and confidence in our professions.

“Finally, it is the way forward in terms of learning from errors and improving our systems so we continuously develop and improve.”

Chair of the Pharmacists’ Defence Association, Mark Koziol, said: “At the PDA we support the duty of candour and this new initiative by the GPhC.

“Taking a frank and honest approach is crucial, even if it means saying sorry and admitting an error has occurred.”

Head of advice and support services for the National Pharmacy Association, Jasmine Shah, said: “We are striving to move away from a blame culture towards a learning culture. It is important to acknowledge when something goes wrong and to help the patient understand what happened. What we aim for is a resolution that is supportive both of the patients and professionals involved.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less